Skip to main content
Clinical Trials/NCT06358274
NCT06358274CompletedNot Applicable

Nutritional and Metabolic Dynamics of Thru-Hiking: A Longitudinal Study on the Colorado Trail

University of Minnesota1 site in 1 country15 target enrollmentStarted: May 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Locations
1
Primary Endpoint
blood lipid panel: triglycerides

Study Overview

Brief Summary

Thru-hiking the Colorado Trail presents distinct challenges owing to its diverse landscapes and high altitudes. The study aims to delve into the physiological and nutritional facets of extended wilderness trekking among thru-hikers. Activities encompass participant recruitment from the Colorado Trail Foundation community, baseline and post-trail assessments including blood lipid panel analysis and anthropometric measurements, data collection during the trail period involving recording daily mileage, exertion levels, and dietary intake, rigorous statistical analysis to explore correlations among various parameters, and adherence to ethical considerations including obtaining formal approval and ensuring informed consent procedures are followed to safeguard participants' rights and privacy. Through this endeavor, the study seeks to offer insights into the metabolic responses and cardiovascular implications associated with thru-hiking, shedding light on the interplay between diet, lifestyle factors, and metabolic health in challenging environments.

The specific aims include examining the metabolic responses and cardiovascular implications associated with thru-hiking, exploring correlations between dietary intake and blood lipid profiles, and elucidating the interplay between lifestyle factors and metabolic health in demanding environments. This study is not limited to program evaluation, quality assurance, or improvement activities within a specific department or setting but rather seeks to contribute to scientific knowledge and inform evidence-based recommendations for individuals engaging in thru-hiking or similar high-intensity activities.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Thru-Hikers on the Colorado Trail:
  • Individuals planning to commence their thru-hiking journey on the Colorado Trail in early July.
  • Participants must reside in northern Colorado.
  • Thru-Hiking History
  • Participants must not have completed another thru-hike in the past 6 months.
  • Informed Consent
  • Individuals interested in participating in the study must provide informed consent.

Exclusion Criteria

  • Individuals who have completed another thru-hike in the past 6 months
  • children below the age of majority, pregnant women, fetuses, and neonates
  • prisoners, adults lacking the capacity to consent or with fluctuating capacity, non-English speakers, and illiterate individuals
  • employees or students of the researcher
  • individuals from undervalued or disenfranchised social groups
  • Active members of the military, including Department of Defense (DoD) personnel
  • individuals in stressful situations, those disadvantaged in social goods and services and individuals with serious health conditions lacking standard treatments
  • those with a fear of negative consequences for not participating and individuals facing circumstances increasing vulnerability to coercion or exploitation

Outcomes

Primary Outcomes

blood lipid panel: triglycerides

Time Frame: baseline and 2 days post-hike

changes in triglycerides levels from baseline to within 2 days of completing the Colorado Trail.

blood lipid panel: low-density lipoprotein (LDL)

Time Frame: baseline and 2 days post-hike

changes in LDL levels from baseline to within 2 days of completing the Colorado Trail.

blood lipid panel: total cholesterol

Time Frame: baseline and 2 days post-hike

changes in total cholesterol levels from baseline to within 2 days of completing the Colorado Trail.

blood lipid panel: high-density lipoprotein (HDL)

Time Frame: baseline and 2 days post-hike

changes in HDL levels from baseline to within 2 days of completing the Colorado Trail.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials